Primera jornada de detección precoz del cáncer de piel, Asocolderma 2011, reporte de la experiencia en Medellín, Colombia
DOI:
https://doi.org/10.29176/2590843X.223Keywords:
Program of skin cancer screening, education, photoprotection, malignant melanoma, squamous cell carcinomaAbstract
In order to project the Dermatology to the general population, to learn about some aspects of the problem of skin cancer and to initiate national public education campaigns, Asocolderma started this program in Medellín as a pilot city. We present the results of the first program realized on May 17, 18 and 19, 2011, with the participation of Universidad CES and Universidad de Antioquia Dermatology grous, and other dermatologists in the city.
Of the 2,404 telephone requests, 1,265 citations were awarded. Malignant or premalignant lesions were suspected in 246 patients, 149 biopsies were taken and atypical nevi or actinic keratoses were suggested clinically in the remainder. There were 2 patients with malignant melanoma, 14 squamous cell carcinomas, 59 basal cell carcinomas, and 1 porocarcinoma. Important information was obtained on the practices of sun exposure and protection in this patient group.
Author Biographies
Margarita María Velásquez
Médica dermatóloga, Doctora en Ciencias Básicas Biomédicas - Inmunología; jefe, Sección de Dermatología, Universidad de Antioquia, Medellín, Colombia; Centro de Investigaciones Dermatológicas, CIDERM; miembro de número de ASOCOLDERMA
Ángela Zuluaga de Cadena
Médica dermatóloga; miembro honorario y presidente honorario de la actual Junta Directiva de Asocolderma
References
1. LeBlanc WG, Vidal L, Kirsner RS, Lee DJ, Caban-Martínez AJ, McCollister KE, et al. Reported skin cancer screening of US adult workers. J Am Acad Dermatol. 2008;59:55-63.
2. Saraiya M, Glanz K, Briss PA, Nichols P, White C, Das D, et al. Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: A systematic review. Am J Prev Med. 2004;27:422-66.
3. Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/ skin cancer screening program experience 2001-2005. J Am Acad Dermatol. 2007;57:60-6.
4. Geller AC, Swetter SM, Oliveria S, Dusza S, Halpern AC. Reducing mortality in individuals at high risk for advanced melanoma through education and screening. J Am Acad Dermatol. 2011;65:S87-94.
5. Demierre MF. Thin melanomas and regression, thick melanomas and older men: Prognostic implications and perspectives on secondary prevention. Arch Dermatol. 2002;138:678-82.
6. Hypolito Silva J, Costa Soares de Sa B, Ribeiro de Avila AL, Landman G, Duprat Neto JP. Atypical mole syndrome and dysplastic nevi: Identification of populations at risk for developing melanoma –review article. Clinics. 2011;66:493-9.
7. Miller DR, Geller AC, Wyatt SW. Melanoma awareness and selfexamination practices: Results of a United States survey. J Am Acad Dermatol. 1996;34:962-7.
8. Smith T. The Queensland Melanoma Project: An exercise in health education. BMJ. 1979;1:253-4.
9. Koh HK, Norton LA, Geller AC, Sun T, Rigel DS, Miller DR, et al. Evaluation of the AAD National Skin Cancer Early Detection and screening program. Part I. J Am Acad Dermatol. 1996;34:971-8.
10. Conejo-Mir J, Bravo J, Díaz-Pérez JL, Fernández-Herrera J, Guillén C, Martí R, et al. Día del Euromelanoma. Resultados en España de las campañas de 2000, 2001 y 2002. Actas Dermosifiliogr. 2005;96:217-21.
11. Qureshi AA, Wei-Passanese EX, Li T, Han J. Host risk factors for the development of multiple non-melanoma skin cancers. J Eur Acad Dermatol Venereol. 2012, Feb 24. doi: 10.1111/j.1468-3083.2012.04483.x.
12. Bozikov K, Taggart I. Metastatic basal cell carcinoma: Is infiltrative/morpheaform subtype a risk factor? Eur J Dermatol. 2006;16:691-2.
13. Dal H, Boldemann C, Lindelöf B. Trends during a half century in relative squamous cell carcinoma distribution by body site in the Swedish population: Support for accumulated sun exposure as the main risk factor. J Dermatol. 2008;35:55-62.
14. Benjamin C, Ananthaswamy HN. p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol. 2007;224:241-8.
15. Bouwes JN, Plasmeijer EI, Feltkamp MC. B papillomavirus infection and skin cancer. J Invest Dermatol. 2008;128:1355-8.
16. Bonerandi JJ, Beauvillain C, Caquant L, Chassagne JF, Chaussade V, Clavère P, et al. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol. 2011;25(Suppl.5):1-51.
17. Feldman SR, Fleischer AB Jr. Progression of actinic keratosis to squamous cell carcinoma revisited: Clinical and treatment implications. Cutis. 2011;87:201-7.
18. Yanofsky VR, Mercer SE, Phelps RG .Histopathological variants
of cutaneous squamous cell carcinoma: A review. J Skin Cancer. 2011;210:8-13.
19. Sanclemente G, Hernández G. Altos índices de radiación ultravioleta en Medellín y en una localidad del oriente antioqueño (Colombia). Iatreia. 2010;23:119-23.
20. Scheneider JS, Moore DH, Mendelsohn ML. Screening program reduced melanoma mortality at the Lawrence Livermore National laboratory, 1984 to 1996. J Am Acad Dermatol. 2008;58:741-9.
21. Sanclemente G, Mahecha M, Guzmán C. Enfermedades de la piel más frecuentes en la consulta dermatológica del Hospital Universitario San Vicente de Paúl y del Hospital Infantil, Medellín, Colombia 1999. Acta Méd Col. 2001;26:240-4.
22. Sánchez G, Nova J, Arias N. Prácticas frente a la radiación ultravioleta y características epidemiológicas de un grupo de pacientes con carcinoma basocelular en un centro de referencia nacional en Colombia. Rev Colomb Cancerol. 2010;14:144-51.
23. González M, Lotero MC, Quiroz L, Navarro M del P, Jaramillo CM, Gaviria MB, et al. Conocimientos y prácticas frente a la exposición solar y tamizaje de cáncer de piel en usuarios de una institución prestadora de salud de Antioquia mayo-junio 2000. Rev Asoc Colomb Dermatol. 2001;9:487-95.
24. Restrepo JC, Zuluaga A, Ochoa FL, Jiménez SB, Castaño OL, Uribe C et al. Jornada de prevención y detección de cáncer de piel en personas mayores de 18 años. Medellín, mayo de 2005. Universidad CES. Rev CES Med. 2009;23:93-103.
25. Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock MA, Daniels S, et al. The first 15 years of the American Academy of Dermatology Skin Cancer Screening Programs: 1985-1999. J Am Acad Dermatol. 2003;48:34-41.
26. Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions. J Am Acad Dermatol. 2007;57:555-72.
27. Stratigos A, Nicolaou V, Kedicoglou S, Antoniou C, Stefapaki I, Hoidemenos G, et al. Melanoma/skin cancer screening in Mediterranean country: Results of the Euromelanoma screening day campaign in Greece. J Eur Acad Dermatol Venereol. 2007;21:56-62.
28. Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012;66:201-11.
29. Rampen FH, Casporie-van Velsen JA, van Huystee BE, Kiemeney LA, Schouten LJ. False negative findings in skin cancer and melanoma screening. J Am Acad Dermatol. 1995;33:59-63.
30. Argenziano G, Zalaudek I, Hofmann-Wellenhof R, Bakos RM, Bergman W, Blum A, et al. Total body skin examination for skin cancer screening in patients with focused symptoms. J Am Acad Dermatol. 2012;66:212-9.
2. Saraiya M, Glanz K, Briss PA, Nichols P, White C, Das D, et al. Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: A systematic review. Am J Prev Med. 2004;27:422-66.
3. Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/ skin cancer screening program experience 2001-2005. J Am Acad Dermatol. 2007;57:60-6.
4. Geller AC, Swetter SM, Oliveria S, Dusza S, Halpern AC. Reducing mortality in individuals at high risk for advanced melanoma through education and screening. J Am Acad Dermatol. 2011;65:S87-94.
5. Demierre MF. Thin melanomas and regression, thick melanomas and older men: Prognostic implications and perspectives on secondary prevention. Arch Dermatol. 2002;138:678-82.
6. Hypolito Silva J, Costa Soares de Sa B, Ribeiro de Avila AL, Landman G, Duprat Neto JP. Atypical mole syndrome and dysplastic nevi: Identification of populations at risk for developing melanoma –review article. Clinics. 2011;66:493-9.
7. Miller DR, Geller AC, Wyatt SW. Melanoma awareness and selfexamination practices: Results of a United States survey. J Am Acad Dermatol. 1996;34:962-7.
8. Smith T. The Queensland Melanoma Project: An exercise in health education. BMJ. 1979;1:253-4.
9. Koh HK, Norton LA, Geller AC, Sun T, Rigel DS, Miller DR, et al. Evaluation of the AAD National Skin Cancer Early Detection and screening program. Part I. J Am Acad Dermatol. 1996;34:971-8.
10. Conejo-Mir J, Bravo J, Díaz-Pérez JL, Fernández-Herrera J, Guillén C, Martí R, et al. Día del Euromelanoma. Resultados en España de las campañas de 2000, 2001 y 2002. Actas Dermosifiliogr. 2005;96:217-21.
11. Qureshi AA, Wei-Passanese EX, Li T, Han J. Host risk factors for the development of multiple non-melanoma skin cancers. J Eur Acad Dermatol Venereol. 2012, Feb 24. doi: 10.1111/j.1468-3083.2012.04483.x.
12. Bozikov K, Taggart I. Metastatic basal cell carcinoma: Is infiltrative/morpheaform subtype a risk factor? Eur J Dermatol. 2006;16:691-2.
13. Dal H, Boldemann C, Lindelöf B. Trends during a half century in relative squamous cell carcinoma distribution by body site in the Swedish population: Support for accumulated sun exposure as the main risk factor. J Dermatol. 2008;35:55-62.
14. Benjamin C, Ananthaswamy HN. p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol. 2007;224:241-8.
15. Bouwes JN, Plasmeijer EI, Feltkamp MC. B papillomavirus infection and skin cancer. J Invest Dermatol. 2008;128:1355-8.
16. Bonerandi JJ, Beauvillain C, Caquant L, Chassagne JF, Chaussade V, Clavère P, et al. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol. 2011;25(Suppl.5):1-51.
17. Feldman SR, Fleischer AB Jr. Progression of actinic keratosis to squamous cell carcinoma revisited: Clinical and treatment implications. Cutis. 2011;87:201-7.
18. Yanofsky VR, Mercer SE, Phelps RG .Histopathological variants
of cutaneous squamous cell carcinoma: A review. J Skin Cancer. 2011;210:8-13.
19. Sanclemente G, Hernández G. Altos índices de radiación ultravioleta en Medellín y en una localidad del oriente antioqueño (Colombia). Iatreia. 2010;23:119-23.
20. Scheneider JS, Moore DH, Mendelsohn ML. Screening program reduced melanoma mortality at the Lawrence Livermore National laboratory, 1984 to 1996. J Am Acad Dermatol. 2008;58:741-9.
21. Sanclemente G, Mahecha M, Guzmán C. Enfermedades de la piel más frecuentes en la consulta dermatológica del Hospital Universitario San Vicente de Paúl y del Hospital Infantil, Medellín, Colombia 1999. Acta Méd Col. 2001;26:240-4.
22. Sánchez G, Nova J, Arias N. Prácticas frente a la radiación ultravioleta y características epidemiológicas de un grupo de pacientes con carcinoma basocelular en un centro de referencia nacional en Colombia. Rev Colomb Cancerol. 2010;14:144-51.
23. González M, Lotero MC, Quiroz L, Navarro M del P, Jaramillo CM, Gaviria MB, et al. Conocimientos y prácticas frente a la exposición solar y tamizaje de cáncer de piel en usuarios de una institución prestadora de salud de Antioquia mayo-junio 2000. Rev Asoc Colomb Dermatol. 2001;9:487-95.
24. Restrepo JC, Zuluaga A, Ochoa FL, Jiménez SB, Castaño OL, Uribe C et al. Jornada de prevención y detección de cáncer de piel en personas mayores de 18 años. Medellín, mayo de 2005. Universidad CES. Rev CES Med. 2009;23:93-103.
25. Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock MA, Daniels S, et al. The first 15 years of the American Academy of Dermatology Skin Cancer Screening Programs: 1985-1999. J Am Acad Dermatol. 2003;48:34-41.
26. Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions. J Am Acad Dermatol. 2007;57:555-72.
27. Stratigos A, Nicolaou V, Kedicoglou S, Antoniou C, Stefapaki I, Hoidemenos G, et al. Melanoma/skin cancer screening in Mediterranean country: Results of the Euromelanoma screening day campaign in Greece. J Eur Acad Dermatol Venereol. 2007;21:56-62.
28. Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012;66:201-11.
29. Rampen FH, Casporie-van Velsen JA, van Huystee BE, Kiemeney LA, Schouten LJ. False negative findings in skin cancer and melanoma screening. J Am Acad Dermatol. 1995;33:59-63.
30. Argenziano G, Zalaudek I, Hofmann-Wellenhof R, Bakos RM, Bergman W, Blum A, et al. Total body skin examination for skin cancer screening in patients with focused symptoms. J Am Acad Dermatol. 2012;66:212-9.
How to Cite
1.
Velásquez MM, Zuluaga de Cadena Ángela. Primera jornada de detección precoz del cáncer de piel, Asocolderma 2011, reporte de la experiencia en Medellín, Colombia. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2012 Apr. 1 [cited 2024 Jul. 3];20(2):135-46. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/223
Downloads
Download data is not yet available.
Downloads
Published
2012-04-01
How to Cite
1.
Velásquez MM, Zuluaga de Cadena Ángela. Primera jornada de detección precoz del cáncer de piel, Asocolderma 2011, reporte de la experiencia en Medellín, Colombia. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2012 Apr. 1 [cited 2024 Jul. 3];20(2):135-46. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/223
Issue
Section
Research Article
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
